Emgality (galcanezumab-gnlm) is a CGRP antagonist for the preventive treatment of migraine and for the treatment of cluster headache. Includes Emgality approval status, regulatory history and clinical trial results. More @Wikipedia
Hover over any link to get a description of the article. Please note that search keywords are sometimes hidden within the full article and don't appear in the description or title.